AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Doxry-CV 325 Tablet

Prescription Icon
Prescription Required

Marketer

Bioclix Remedies

Salt Composition

Cefpodoxime Proxetil (200mg) + Clavulanic Acid (125mg)

Overview Doxry-CV 325 Tablet

Combivir-325 tablets contain a dual-action formulation indicated for respiratory infections. This medication combats existing infection and inhibits further microbial proliferation. Combivir-325 is available only with a prescription and should be taken as directed. Administration with or without food is acceptable, but consistent timing is crucial for optimal results. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken upon recollection. Complete the entire treatment regimen, even with symptom improvement; premature cessation may compromise effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, a nutritious diet, and sufficient hydration will aid recovery. Your doctor may order laboratory and imaging studies to monitor treatment response.

Primary Ingredients of Doxry-CV 325 Tablet

No text was provided. Please provide the text you would like me to rephrase.

Uses of Doxry-CV 325 Tablet

Managing respiratory infections

Major Benefits of Doxry-CV 325 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Doxry-CV 325 Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Consumption with or without food is acceptable, though consistent timing is recommended.

Common Side effects of Doxry-CV 325 Tablet:

  • Nausea
  • Diarrhea
  • Headache
  • Rash
  • Abdominal pain
  • Vaginal infection
  • Fungal infection of vagina

How to use Doxry-CV 325 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Doxry-CV 325 Tablets. Ingest the tablet whole; do not break, crush, or chew it. While Doxry-CV 325 Tablets can be administered with or without food, consistent timing is recommended.

How Doxry-CV 325 Tablet works:

Doxry-CV 325 Tablet unites Cefpodoxime Proxetil, an antibiotic, with Clavulanic Acid, a beta-lactamase inhibitor. Cefpodoxime Proxetil's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Clavulanic Acid counters bacterial resistance mechanisms, thereby boosting Cefpodoxime Proxetil's antibacterial efficacy.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The interaction of alcohol with Doxry-CV 325 Tablet is undetermined; therefore, physician consultation is advised before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Doxry-CV 325 Tablet is generally deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, clinical data in humans are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Lactation and Doxry-CV 325 Tablet use are compatible. Research in humans indicates negligible transfer of the medication into breast milk, posing no apparent risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Doxry-CV 325 Tablet side effects, including allergic reactions, dizziness, or seizures.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Doxry-CV 325 Tablets. Dosage modification may be necessary; physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Doxry-CV 325 Tablet's use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Doxry-CV 325 Tablet :

Should you forget a Doxry-CV 325 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Doxry-CV 325 Tablet

LabelValue
Potential for Dependence None.
Type of Medication Drugs combating infection

FAQs on Doxry-CV 325 Tablet

Doxry-CV 325 Tablets may induce diarrhea as a side effect. This antibiotic eliminates harmful bacteria, but this action can also impact beneficial gut flora, resulting in diarrhea. Consult your physician if you develop severe diarrhea.
The effects of Doxry-CV 325 Tablet typically begin shortly after administration. Complete eradication of harmful bacteria and noticeable symptom improvement, however, might require several days.
Consult your physician if your condition hasn't improved following completion of the prescribed medication regimen. Similarly, report any worsening of symptoms during treatment.
Discontinue Doxry-CV 325 Tablet only upon completion of the prescribed regimen. Continue taking the medication as directed, even with symptom improvement; full recovery necessitates the entire treatment course.
Cefpodoxime and clavulanate potassium, combined in Doxry-CV 325 tablets, combat bacterial infections. The drug's mechanism involves eradicating the infectious bacteria.
Rarely (less than one in a thousand patients) does Doxry-CV 325 Tablet produce severe adverse reactions. Seek immediate medical advice if you experience bloody stools, jaundice (yellowing of skin and eyes), easy bruising or unusual skin discoloration, breathlessness, widespread skin eruption, skin shedding, or fever. These symptoms require prompt medical intervention.
Continue taking Doxry-CV 325 Tablets as prescribed and finish the entire course, regardless of feeling better. Symptom relief doesn't guarantee complete infection eradication.
Doxry-CV 325 Tablets may trigger allergic responses and are contraindicated for individuals with documented hypersensitivity to cephalosporin antibiotics. Seek immediate medical attention if you experience allergic symptoms such as urticaria, respiratory distress, or swelling of the face, lips, tongue, or throat.
Patients exhibiting hypersensitivity to penicillin or any Doxry-CV 325 Tablet component should avoid its use. Prior instances of liver injury linked to Doxry-CV 325 Tablet contraindicate its administration.
Doxry-CV 325 Tablets can reduce the effectiveness of oral contraceptives. Therefore, consult your physician regarding alternative birth control options that don't influence hormone levels, like condoms, diaphragms, or spermicides.
Exceeding the prescribed dosage of Doxry-CV 325 Tablets elevates the likelihood of adverse reactions. Therapeutic efficacy with Doxry-CV 325 Tablets develops gradually. Should your symptoms worsen, seek medical advice for reassessment.
Retain this medication within its original, securely sealed container or packaging. Follow the storage directions provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and other individuals.
Doxry-CV 325 Tablet
167
MRP 204
18% off